Anja Kammesheidt

Pathway Genomics has named Anja Kammesheidt its vice president of research and development. She joins the firm from Agendia where she worked on genomics-based personalized diagnostics and directed translational science projects. Prior to that, she served as chief scientific officer at Ambry Genetics for 10 years.

Kammesheidt received her bachelor and doctoral degrees in biological sciences from the University of California, Irvine, with a focus on molecular neurobiology. After completing her postdoctoral training at the University of California, San Diego, she joined Purdue Pharma as a research scientist focused on neuropathic pain targets.